Home › Funds › SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC › CSTL

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC position in CSTL

CASTLE BIOSCIENCES INC · Health Care

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC reported holding 635,000 shares of CSTL (CASTLE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$22.6M, representing 0.67% of its reported portfolio and ranking #44 among its reported holdings. SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has disclosed CSTL holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)635.00K sh
Reported value held$22.56M
Portfolio Weight0.67%
First reportedQ3 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's CSTL position evolved

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC first disclosed a stake in CSTL in Q3 2025 at 400,000 shares (US$9.1M). The position peaked in Q4 2025 at 1,058,725 shares, worth US$41.2M. Across 5 filings, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 635,000 shares valued at US$22.6M — a reduction of -189,872 shares quarter over quarter.. Notable position changes include a 165% increase in Q4 2025 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 400.00K $9.11M New
Q4 2025 1.06M $41.18M Add
Q1 2026 940.68K $23.09M Reduce
Q2 2026 824.87K $19.67M Reduce
Q3 2026 635.00K $22.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CSTL and 13F data

CSTL (CASTLE BIOSCIENCES INC) is a Health Care company. 33 other funds we track also report a position in CSTL — the largest reported positions include RTW INVESTMENTS, LP (US$98.7M), Parkman Healthcare Partners LLC (US$13.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CSTL

All CSTL fund holders →

FAQ

How long has SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC held CSTL?

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has disclosed CSTL holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's current position in CSTL?

As of Q3 2026, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC holds 635.00K shares of CSTL (CASTLE BIOSCIENCES INC), valued at $22.56M, representing 0.67% of its reported portfolio and ranking #44.

Has SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC been buying or selling CSTL?

In the latest 13F filing (Q3 2026), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC reduced its position in CSTL. The position peaked in Q4 2025 at 1.06M shares.

Which other funds hold CSTL?

Other major institutional holders of CSTL include RTW INVESTMENTS, LP, Parkman Healthcare Partners LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.